- Global Pharma News & Resources

Global Flow Cytometry Market is expected to grow at a CAGR of 9.60% during the forecast period from 2018-2025

A new research report published by Fior Markets with the title Global Flow Cytometry Market by Technology (Cell-Based Flow Cytometry, Bead-Based Flow Cytometry), Product & Service, Application, End-Users, and Region and Global Forecast 2018-2025.

As per the report, the global flow cytometry market is expected to grow from USD 4,100.92 Million in 2017 to USD 8,590.71 Million by 2025 at a CAGR of 9.60% during the forecast period from 2018-2025. North America is expected to dominate the market during the forecast period. North America exhibiting huge market potential due to presence of supportive government reforms, advanced technologies for molecular diagnostics and availability of skilled professionals in the region. These factors are contributing to market growth.


Prominent players operating in the market are Thermo Fisher Scientific, Agilent Technologies, Sysmex Partec, Apogee Flow Systems, Stratedigm, Beckman Coulter, Sony Biotechnology, Becton, Dickinson and Company, Miltenyi Biotec, Biomérieux S.A., Merck KGaA, Bio-Rad Laboratories, Cytonome St, Enzo Life Sciences, Luminex and others. Major firms are incorporating various strategies to increase their market reach. For instance, in 2018, Becton, Dickinson and Company launched BD FACSymphony S6 High Parameter Cell Sorter. In addition, in 2018, Merck KGaA also launched the CellStream benchtop flow cytometer system.

The technology segment is divided into cell-based and bead-based flow cytometry. The bead-based technology segment held the largest market share and was valued around USD 2,214.72 million in 2017. Cell-based technology offers advantages including its capacity to detect multiple analytes, high reproducibility, stability, and speed. The product and service segment is classified into reagents and consumables, instruments, services, software and accessories. Reagents and consumables segment is dominating and held the largest market share in 2017. Requirement and commercialization of high-quality application-specific reagents and assays by end users is supporting the growth of the segment. Application segment includes research applications, clinical applications and industrial applications. Research segment is expected to grow at lucrative CAGR in the forecast period. Increasing R&D pertaining to cancer and other infectious diseases and various applications in several industries such as food microbiology and plant tissue culture are driving the growth of the segment. End user segment is categorised into academic and research institutes, hospitals & clinical testing laboratories and pharmaceutical & biotechnology companies. Hospitals segment is expected to dominate in 2017. Increasing diagnostic tests rising, prevalence of chronic and infectious diseases and growing awareness are contributing to the growth of the segment

Increasing use of flow cytometry in hospitals and diagnostic centers for disease diagnosis such as cancer, HIV, and hematological malignancies propelling the growth of the market in forecast period. In addition, growth in health care infrastructure is also boosting the growth of the market. High cost of equipment in emerging economies may restrict the growth of the market. However, medical advancements in the field of flow cytometry and increasing applications of flow cytometry are augmenting the growth of the market in forecast period.


About the report: 
The global flow cytometry market is analysed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.

Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Contact Us
Mark Stone
Phone: +1-201-465-4211

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 07-Jul-2020